Premarket Decliner
CGTX Cognition Therapeutics3.06+0.20+7.2%
Premarket:2.47-0.59 (-19.3%)
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
Globe NewswireWed, 27-Aug 8:53 PM
After Hours Gainer
CGTX Cognition Therapeutics2.37+0.27+12.9%
After Hours:3.63+1.26 (+53.2%)
Cognition Therapeutics to Host Investor Webcast to Discuss Results from Proof-of-Concept Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer's Disease at 8:30am ET on Monday July 29, 2024
Globe NewswireFri, 26-Jul 4:11 PM
After Hours:4.10+1.73 (+73.0%)
